NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹36 Cr | ₹20 Cr | ₹35 Cr | ₹14 Cr | ₹27 Cr |
What is the latest Cash Flow from Operating Activities ratio of NGL FINECHEM ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹27 Cr |
How is Cash Flow from Operating Activities of NGL FINECHEM Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 75.04 | |
| Mar2024 | ₹20 Cr | -42.00 | |
| Mar2023 | ₹35 Cr | 155.23 | |
| Mar2022 | ₹14 Cr | -49.46 | |
| Mar2021 | ₹27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,331.0 Cr | -4.3% | -6.4% | 78.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -4.3% |
-6.4% |
78.8% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses